Vorinostat Suspended Phase 0 Trials for Uveal Melanoma Treatment

IndicationsStatusPurposePhase
SuspendedTreatment0
clinicaltrials.gov IdentifierTitleDrugs
NCT03022565Vorinostat in Patients With Class 2 High Risk Uveal Melanoma